Search
Quercus acutissima whole
go.drugbank.com/drugs/DB14373InvestigationalQuercus acutissima whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Mixtures: Dr. Forest Hand Sanitizer, Dr. Forest Hand SanitizerChamaecyparis obtusa whole
go.drugbank.com/drugs/DB16632InvestigationalMixtures: Dr. Forest Hand Sanitizer, Dr. Forest Hand SanitizerCryptomeria japonica bark
go.drugbank.com/drugs/DB16633InvestigationalMixtures: Dr. Forest Hand Sanitizer, Dr. Forest Hand SanitizerOxibendazole
go.drugbank.com/drugs/DB04910ExperimentalVet approvedOxibendazole is a polymerase inhibitor in phase III trials for the treatment of helminth intestinal infections.
Metenkefalin
go.drugbank.com/drugs/DB12668InvestigationalMetenkefalin is an endogenous opioid and beta-endorphin. It has been shown to reduce chromosomal abberations in patients with multiple sclerosis. Metenkefalin, along with tridecactide, are under investigation as an immunomodulatory thera...
Categories: mu-Opioid Receptor AgonistTeglarinad chloride
go.drugbank.com/drugs/DB05217InvestigationalGMX1777 is a water-soluble prodrug of the cyanoguanidine compound GMX1778 with potential antineoplastic activity. In vivo, apoptosis inducer GMX1777 is rapidly converted into GMX1778 through hydrolytic cleavage of a carbonate ester bond....
Hu-PHEC Liver
go.drugbank.com/drugs/DB18347ExperimentalHu-PHEC Liver is an adult hemogenic endothelial cells.
Synonyms: Hu-PHEC LiverAlosetron
go.drugbank.com/drugs/DB00969ApprovedWithdrawnAlosetron was voluntarily withdrawn from the US market in November 2000 by the manufacturer due to numerous reports of severe adverse effects including ischemic colitis, severely obstructed or ruptured
Yohimbine
go.drugbank.com/drugs/DB01392ApprovedInvestigationalVet approvedWithdrawnA plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of impotence. It is also alleged to be an aphrodisiac.
Categories: Dopamine D2 Receptor AntagonistsAtezolizumab
go.drugbank.com/drugs/DB11595ApprovedInvestigational[A18493,L7489] This medication is reserved for patients whose tumors express PD-L1, cannot receive platinum-based chemotherapy, or whose tumors do not respond to platinum-based chemotherapy.